» Articles » PMID: 33813928

Layperson Views About the Design and Evaluation of Decision Aids: A Public Deliberation

Overview
Publisher Sage Publications
Date 2021 Apr 5
PMID 33813928
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: We carried out the first public deliberation to elicit lay input regarding guidelines for the design and evaluation of decision aids, focusing on the example of colorectal ("colon") cancer screening.

Methods: A random, demographically stratified sample of 28 laypeople convened for 4 days, during which they were informed about key issues regarding colon cancer, screening tests, risk communication, and decision aids. Participants then deliberated in small and large group sessions about the following: 1) What information should be included in all decision aids for colon screening? 2) What risk information should be in a decision aid and how should risk information be presented? 3) What makes a screening decision a good one (reasonable or legitimate)? 4) What makes a decision aid and the advice it provides trustworthy? With the help of a trained facilitator, the deliberants formulated recommendations, and a vote was held on each to identify support and alternative views.

Results: Twenty-one recommendations ("deliberative conclusions") were strongly supported. Some conclusions matched current recommendations, such as that decision aids should be available for use with and without providers present (conclusions 1-4) and should support informed choice (conclusion 9). Some conclusions differed from current recommendations, at least in emphasis-for example, that decision aids should disclose cost of screening (conclusion 11) and should be kept simple and understandable (conclusion 14). Deliberants recommended that decision aids should disclose the baseline risk of getting colon cancer (conclusions 15, 17).

Limitations: Single location and medical decision.

Conclusions: Guidelines for design of decision aids should consider putting a greater focus on disclosing cost and keeping decision aids simple, and they possibly should recommend disclosing less extensive amounts of quantitative information than currently recommended.

Citing Articles

A 4-Site Public Deliberation Project on the Acceptability of Youth Self-Consent in Biomedical HIV Prevention Trials: Assessment of Facilitator Fidelity to Key Principles.

Draucker C, Carrion A, Ott M, Hicks A, Knopf A JMIR Form Res. 2025; 9:e58451.

PMID: 39946717 PMC: 11888116. DOI: 10.2196/58451.


Research data use in a digital society: a deliberative public engagement.

McGrail K, Teng J, Bentley C, ODoherty K, Burgess M Int J Popul Data Sci. 2024; 9(1):2372.

PMID: 39620125 PMC: 11606539. DOI: 10.23889/ijpds.v9i1.2372.


Making the BEST decision-the BESTa project development, implementation and evaluation of a digital Decision Aid in Swedish cancer screening programmes- a description of a research project.

Fritzell K, Hedberg B, Woudstra A, Forsberg A, Sventelius M, Kottorp A PLoS One. 2023; 18(12):e0294332.

PMID: 38085710 PMC: 10715660. DOI: 10.1371/journal.pone.0294332.


Mixed-Method Systematic Review and Meta-Analysis of Shared Decision-Making Tools for Cancer Screening.

Herrera D, van de Veerdonk W, Berhe N, Talboom S, van Loo M, Alejos A Cancers (Basel). 2023; 15(15).

PMID: 37568683 PMC: 10417450. DOI: 10.3390/cancers15153867.


Adding epitope compatibility to deceased donor kidney allocation criteria: recommendations from a pan-Canadian online public deliberation.

Edwards L, Bentley C, Burgess M, Sapir-Pichhadze R, Hartell D, Keown P BMC Nephrol. 2023; 24(1):165.

PMID: 37296384 PMC: 10255937. DOI: 10.1186/s12882-023-03224-z.


References
1.
Blalock S, Reyna V . Using fuzzy-trace theory to understand and improve health judgments, decisions, and behaviors: A literature review. Health Psychol. 2016; 35(8):781-792. PMC: 4979567. DOI: 10.1037/hea0000384. View

2.
Hawkes N . "Citizens' jury" disagrees over whether screening leaflet should put reassurance before accuracy. BMJ. 2012; 345:e8047. DOI: 10.1136/bmj.e8047. View

3.
Street J, Duszynski K, Krawczyk S, Braunack-Mayer A . The use of citizens' juries in health policy decision-making: a systematic review. Soc Sci Med. 2014; 109:1-9. DOI: 10.1016/j.socscimed.2014.03.005. View

4.
Ubel P, Abernethy A, Zafar S . Full disclosure--out-of-pocket costs as side effects. N Engl J Med. 2013; 369(16):1484-6. DOI: 10.1056/NEJMp1306826. View

5.
Smith L, Webster R, James Rubin G . A systematic review of factors associated with side-effect expectations from medical interventions. Health Expect. 2020; 23(4):731-758. PMC: 7495066. DOI: 10.1111/hex.13059. View